According to Merck KGaA's latest financial reports the company's current EPS (TTM) is 6,56 โฌ. In 2022 the company made an earnings per share (EPS) of 7,07 โฌ a decrease over its 2021 EPS that were of 7,20 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | 7,08 โฌ | 0.1% |
2022 | 7,07 โฌ | -1.74% |
2021 | 7,20 โฌ | 53.88% |
2020 | 4,68 โฌ | 56.65% |
2019 | 2,99 โฌ | -62.19% |
2018 | 7,90 โฌ | 29.13% |
2017 | 6,11 โฌ | 66.49% |
2016 | 3,67 โฌ | 46.27% |
2015 | 2,51 โฌ | -18.21% |
2014 | 3,07 โฌ | -5.25% |
2013 | 3,24 โฌ | 114.63% |
2012 | 1,51 โฌ | -10.04% |
2011 | 1,68 โฌ | -0.45% |
2010 | 1,69 โฌ | 60.54% |
2009 | 1,05 โฌ |